Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Mirum Pharmaceuticals Q1 2026 Earnings Call - Raised 2026 Revenue Guidance to $660M-$680M on Strong LIVMARLI Uptake and Rare Disease Pipeline Expansion
Mirum Pharmaceuticals delivered a quarter defined by execution and strategic expansion, raising full-year revenue guidance to $660 million-$680 million on robust uptake of LIVMARLI, particularly in th...
- Mirum raised full-year 2026 revenue guidance to $660 million-$680 million, up from previous estimates, driven by strong LIVMARLI uptake in adult PFIC patients and better-than-expected international sales.
- First-quarter 2026 net product sales reached approximately $160 million, with LIVMARLI generating $84 million in the U.S. and $30 million internationally, while bile acid medicines contributed $46 million.
- The company is expanding its U.S. liver commercial team from 20 to approximately 60 personnel by early 2027 to cover adult prescribers for PSC, hepatitis delta, and broader rare liver diseases.
- +7 more takeaways
H&R Block Q3 FY2026 Earnings Call - Assisted Channel Market Share Stabilizes as AI-Driven Expertise Gains Traction
H&R Block delivered a strong third quarter of fiscal 2026, beating expectations on revenue, EBITDA, and adjusted EPS while raising its full-year outlook. The company stabilized its assisted channel ma...
- H&R Block beat Q3 fiscal 2026 expectations, reporting revenue of $2.4 billion (up 5.3% YoY), EBITDA of $1.1 billion (up 5.9%), and adjusted EPS of $6.02 (up 11.9%).
- The company raised its full-year fiscal 2026 guidance, now expecting revenue of $3.91-$3.92 billion, EBITDA of $1.025-$1.035 billion, and adjusted EPS of $5.10-$5.20.
- Assisted channel market share stabilized this tax season, holding flat against industry growth after two consecutive years of progressive improvement, marking a key inflection point.
- +9 more takeaways
Evertec Q1 2026 Earnings Call - Dimensa Acquisition Closes, Full-Year Outlook Raised Amid Latin America Growth
Evertec reported strong Q1 2026 results, driven by a full quarter contribution from Tecnobank and organic growth across segments, with revenue up 8% year-over-year to $247.9 million. The company close...
- Evertec closed the Dimensa acquisition, expanding its footprint in Latin America’s insurance and risk management verticals and positioning itself as a larger financial SaaS provider.
- Q1 2026 revenue reached $247.9 million, up 8% year-over-year, with constant currency growth of approximately 5%.
- Full-year 2026 revenue guidance raised to $1.073-$1.085 billion, reflecting 15.1%-16.4% reported growth and 13.8%-15% constant currency growth.
- +7 more takeaways
Blue Bird Corporation Q2 FY2026 Earnings Call - Record Profits and Strategic Acquisition Lift Outlook
Blue Bird delivered a record second quarter for fiscal 2026, beating guidance on every metric with $51 million in Adjusted EBITDA and $40 million in free cash flow. The company sold 2,148 buses, with ...
- Record Q2 Adjusted EBITDA of $51 million and free cash flow of $40 million, beating guidance for the 14th consecutive quarter.
- Full-year revenue guidance raised to $1.725 billion-$1.775 billion, with Adjusted EBITDA projected at $235 million-$255 million post-Micro Bird acquisition.
- Completed acquisition of the remaining 50% stake in Micro Bird JV, expanding total addressable market by 78% and adding Buy America commercial shuttle bus capabilities.
- +7 more takeaways
HCI Group First Quarter 2026 Earnings Call - Record Earnings Drive Aggressive Share Buybacks
HCI Group delivered a record first quarter with pre-tax income up 15% to $115 million and diluted EPS of $5.45. The company reported an 8% growth in gross premiums earned and a 12% increase in total r...
- Pre-tax income grew 15% year-over-year to $115 million, with diluted EPS of $5.45, marking the strongest first quarter in company history.
- Gross premiums earned increased just over 8%, while total revenue surged more than 12% due to significant growth in investment and other income.
- The combined ratio held steady at 57%, matching full-year 2025 performance, and management is targeting a 60% ±5% combined ratio going forward.
- +7 more takeaways
Central Garden & Pet Fiscal 2026 Q2 Earnings Call - Record Quarter Driven by Operational Discipline and Strategic Simplification
Central Garden & Pet delivered a record second quarter and first half in fiscal 2026, driven by strong execution, operational simplification, and resilient demand across both Pet and Garden segments. ...
- Central Garden & Pet reported record Q2 and H1 fiscal 2026 results with net sales of $906 million, up 9% year-over-year, driven by strong underlying demand and favorable timing shifts.
- Operating margin expanded to 12.6% in Q2 from 11.2% in the prior year, with gross margin improving 30 basis points to 33.1%, reflecting productivity gains and mix benefits.
- Diluted EPS reached a record $1.28, beating expectations and supporting maintained full-year guidance of $2.70 or better, excluding acquisitions and restructuring.
- +7 more takeaways
Zevia Q1 2026 Earnings Call - Record Sales Growth Driven by Cardi B Partnership and Cost Discipline
Zevia delivered a record first quarter in 2026, with net sales jumping 21.2% to $46.1 million and adjusted EBITDA flipping to a positive $0.9 million from a $3.3 million loss a year earlier. The surge...
- Net sales grew 21.2% year-over-year to $46.1 million, marking the highest growth rate since the company went public.
- Adjusted EBITDA turned positive at approximately $0.9 million, a significant improvement from a $3.3 million loss in the prior year period.
- Management raised full-year net sales guidance to $170 million–$175 million, reflecting a 7% growth midpoint, but lowered full-year adjusted EBITDA expectations to a loss of $2 million–$4 million.
- +7 more takeaways
Quanterix Q1 2026 Earnings Call - New CEO Executes Sharp Commercial Pivot and Accelerates Alzheimer's Diagnostics Push
Quanterix delivered a mixed Q1 2026 report that underscores a company in active transition. Revenue rose 20% year-over-year to $36.4 million, but organic growth declined 21% as academic and pharma end...
- Revenue rose 20% YoY to $36.4 million, but organic revenue declined 21%, reflecting sluggish academic and pharma end-markets.
- New CEO Everett Cunningham is executing a sharp strategic pivot, shifting focus from synergy integration to aggressive growth and commercial execution.
- The company successfully delivered the $85 million in annualized cost synergies from the Akoya acquisition, allowing the combined entity to operate at pre-acquisition expense levels.
- +10 more takeaways
Ethos Technologies Q1 2026 Earnings Call - Revenue Doubles as Platform Economics Scale and Guidance Rises
Ethos Technologies delivered a record first quarter, more than doubling revenue year-over-year to $193 million while protecting over 88,000 new policies. The company’s vertically integrated platform c...
- Revenue surged 104% year-over-year to $193 million, driven by 136% growth in the direct channel and 42% growth in the third-party channel.
- Adjusted EBITDA reached $34 million, supported by a Rule of 40 score of 121, reflecting strong growth and profitability despite a one-time charge.
- Management raised full-year 2026 revenue guidance to $561–$565 million and adjusted EBITDA guidance to $103–$107 million.
- +7 more takeaways
IBEX Q3 FY 2026 Earnings Call - Record Revenue Growth Driven by Health Tech Expansion and Sierra AI Partnership
IBEX delivered another quarter of outsized execution, posting record revenue of $164.4 million, up 17% year-over-year, and adjusted EPS of $0.91, up 11%. The growth was not a broad sweep. It was highl...
- Record revenue of $164.4 million, up 17% year-over-year, driven by broad-based growth across verticals and geographic regions.
- Health tech vertical emerged as the primary growth engine, surging 54% and on track to exceed $100 million in annual revenue by year-end.
- Technology vertical grew 43%, while telecommunications declined 23.1%, indicating a deliberate shift away from lower-margin legacy clients.
- +7 more takeaways